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Previous research has shown increased saccade latencies in patients with 
Alzheimer’s disease and mild cognitive impairment; however, this is not well-understood 
in patients with delirium. The present study investigates eye-tracking metrics to evaluate 
the feasibility of using eye-tracking to discern delirious patients from disease control 
patients. We recruited 24 participants from the inpatient and intensive care units (ICU) at 
Massachusetts General Hospital (MGH) and assessed for delirium via CAM-S, a 
screening tool for delirium. Participants were instructed to follow a dot stimulus as it 
moves across the laptop screen as their eye movements were simultaneously tracked by a 
Tobii Pro Fusion eye-tracker. Our experimental paradigm involved gap saccades (central 
fixation extinguishes before the centrifugal target appears), overlap saccades (central 
fixation remains after centrifugal target onset), horizontal smooth pursuit, and circular 
smooth pursuit tasks. The eye-tracking metrics discussed in this study are the calibration 
and validation accuracies, saccade latencies and total target gaze duration. Our eye-
tracking method was able to capture subjects’ gaze direction and path, but further 
research is needed to draw strong conclusions about the feasibility to detect oculomotor 
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What is Delirium? 
Delirium is the acute onset of fluctuating mental status and disturbance in 
attention and may also present itself with other cognitive deficits such as memory 
impairment or disorientation. The mental status seen in delirious patients changes rapidly, 
occurs over several hours to days, and often fluctuates. According to the Diagnostic 
Statistical Manual of Mental Disorders, fifth edition (DSM-5), the diagnostic criteria for 
delirium includes an interruption in attention and awareness that develops over a short 
period of time, and another disturbance in cognition (Lawlor & Bush, 2014). The 
presentation of the delirious state can vary widely thus complicating the diagnostic and 
screening process and leaving the pathophysiological processes of delirium poorly 
understood. In addition, delirium is multifactorial; its causes may come from many 
different origins and can be metabolic, neurologic, or environmental in nature (Tulebaev, 
Inouye, & Fong, 2009). This often results in misdiagnosing or underdiagnosing delirium 
in patients.  
 
Prevalence of Delirium 
While delirium is not common in the general community, the incidence of 
delirium in a hospital setting may range widely depending on the type of care patients are 




receiving major elective surgery ranged from 15 to 25% and increased to 50% after high-
risk procedures such as joint replacement surgery and cardiac surgery (Marcantonio & 
Solomon, 2017). The notable risk factors include dementia and advanced age , which 
contribute to the high occurrence of delirium. The incidence of delirium in elderly 
patients admitted to the ICU then increases to about 70-87%  (Tulebaev, Inouye, & Fong, 
2009). The diverse etiologies and presentation of delirium in addition to its high rate in 
ICUs calls for improved screening and detection (Lawlor & Bush, 2014). Furthermore, 
many hospital staff who routinely provide care for delirious patients lack the specific 
training and knowledge to properly assess the patient. With more objective and accurate 
screening for delirium, we may be able to offset the negative consequences of 
misdiagnosing delirium such as increase in the length of hospital stay, cognitive 
impairment, and mortality that patients face.  
 
Available Tools for Delirium Assessment 
In the ICU, the common tools used to detect delirium include the Confusion 
Assessment Method (CAM-ICU) and the Intensive Care Delirium Screening Checklist 
(ICDSC). Both screening tools are designed for patients staying in the hospital ICU. The 
CAM-ICU assesses for the presence of acute onset and fluctuating course, altered 
consciousness, inattentiveness, and disorganized thinking. The presence of acute onset 
and fluctuating course and inattention along with the presence of either altered level of 




reflects the DSM-5 criteria for delirium. The ICDSC’s scale is designed for patients who 
have limited ability to communicate such as those who have been intubated. This tool 
assesses patients’ level of consciousness, hallucinations, disorientation, psychomotor 
activity, inappropriate speech, sleep quality, inattentiveness, and fluctuation of 
symptoms. The score for the ICDSC ranges from 0 to 8; scores of 4 or higher is 
indicative of delirium. (Boettger, et al., 2018). CAM-ICU has a sensitivity of 80% and 
specificity of 95.9%, while ICDSC has a sensitivity of 74% and specificity of 81.9% 
(Gusmao-Flores, Salluh, Chalhub, & Quarantini, 2012). The CAM- ICU offers the higher 
sensitivity and specificity in diagnosing delirium. 
Because delirium is the result of many potential underlying conditions and is 
insufficiently understood, there are no biomarkers that clinicians currently use to 
diagnose delirium. Ultimately, diagnostic tools heavily rely on medical history, 
observation, and assessment of cognition (Tieges, Evans, Neufeld, & MacLullich, 2018). 
The CAM-S, like the CAM-ICU, can assess for the diagnostic features of delirium. 
Unlike the CAM-ICU, CAM-S can provide more insight on patient’s level of severity in 
each delirium feature. The CAM-S long form contains 10 items with a score range of 0 to 
19 (19 is most severe). The 10 items included the acute onset or symptom fluctuation, 
altered level of consciousness, altered sleep-wake cycle, disorientation, inattention, 
disorganized thinking, perceptual disturbances, psychomotor agitation, psychomotor 
retardation, and memory deficits. Each feature is scored 0-2, except for the acute onset or 




available for delirium detection, there is a demand for more accurate and objective tests 
to assess for delirium.  
 
Eye-tracking for Detecting Attentional Deficits 
Eye-tracking research has been around for centuries and the need for accurate 
measures of eye gaze has led to the advancement in eye-tracking technology. In the 19th 
century, scientists such as French ophthalmologist, Louis Émile Javal, studied eye 
movements without modern day technology by regular observation. Through these 
observations, Javal noticed that subjects’ eye movements were not continuous as they 
read through lines of text and proposed that the reading process involves brief, abrupt eye 
movements followed by pauses or fixations. Javal then introduced the French term 
“saccades” to describe these short eye movements, which translates to “jerks” in English. 
His method for counting saccades involved attaching a microphone to subjects’ upper 
eyelid and counting each time he heard the readers’ eyes jerk (Płużyczka, 2018; Wade, 
2010).  By the 20th century, eye-tracking technology began to emerge when Edmund 
Huey invented contact lenses that connected to an aluminum indicator that shows the 
participants’ eye movements. However, this device was incredibly invasive, which lead 
Raymond Dodge to design a photographic eye-tracker that did not require attachment to 
the eye to capture its movements (Wade, 2010). Through the centuries, eye-tracking 
devices have been refined and advanced and have truly made an impact on the way 





Recently, studies have promisingly demonstrated the potential in eye-tracking 
data to serve as biomarkers for neurological conditions. By extracting and analyzing the 
quantitative gaze data, researchers notice differences in the data between patients with 
attention deficit hyperactivity disorder (ADHD) and control participants (Terao, Fukuda, 
& Hikosaka, 2017). Inattention is a core feature of delirium and can be captured through 
eye-tracking in several ways. Since Javal’s introduction to saccades, saccades have often 
been used by researchers to understand not only motor function, but also cognition (Leigh 
& Kennard, 2004). Cognitively healthy individuals are able to disengage their attention 
towards an irrelevant stimulus and shift their attention towards the target sooner than 
individuals with attentional deficits, especially patients with Alzheimer’s disease 
(Malhotra, 2019). The gap and overlap saccade paradigms have been studied for its 
ability to assess this attentional disengagement in this patient population (Crawford, et 
al., 2013). In the gap saccade paradigm, there is a brief ‘gap’ in time between the removal 
of the central fixation and the onset of the new peripheral target. In the overlap saccade 
paradigm, the central fixation stays on as the new peripheral target appears and the 
presentation of the two stimuli ‘overlaps’ for a short period before the central fixation 
disappears. The measure of the gap effect is the difference in saccade latencies between 
the gap and overlap saccades. Because the overlap saccade requires greater effort for an 
individual to disengage attention from the central fixation, subjects may require more 




patients with Alzheimer’s disease, it was found that their gap effect is greater than 
healthy controls (Yang, Wang, Su, Xiao, & Kapoula, 2013). The subjects’ ability or 
inability to attentionally disengage from a non-target stimulus and subsequently shift 
attention towards the target stimulus may provide useful information about their 
cognitive functioning in attention-impaired conditions such as delirium. 
 
Smooth Pursuit 
Another method to assess attention by eye-tracking is through a smooth pursuit 
paradigm. According to Contreras et al. (2008), smooth pursuit eye movement is heavily 
dependent on attentional processes. The smooth pursuit paradigm involves a target that 
moves continuously across a distance without interruption and this movement often 
prompts subjects to follow the target with their eyes. The task requires subjects to sustain 
their attention in order to follow the target’s continuous path, therefore, weakened 
attention during this task would disrupt the subject’s tracking of the target. The neurons 
in the middle and superior temporal areas are activated by visual motion stimulation; 
moreover, activation is enhanced when subjects are asked to pay attention to a certain 
attribute of the path of the target. Studies have shown that visual search tasks are 
performed more accurately and quickly when targets are being pursued than those that 
are not due to the increased attentional efforts (Van Donkelaar & Drew, 2002). The 
smooth pursuit task has been found to be suitable for early detection of cognitive deficits 




Klingberg, 1991). In addition, in other conditions where attention is impaired such as 
schizophrenia and ADHD, smooth pursuit is disrupted (Van Donkelaar & Drew, 2002). 
Attentional deficits have also been captured by horizontal and circular smooth pursuit 
paradigms in patients with mild traumatic brain injury (mTBI), where the connection 
between the frontal cortex and cerebellum is damaged. Furthermore, smooth pursuit 
performance in patients with mTBI is highly variable (Contreras, Ghajar, Bahar, & Suh, 
2011; Maruta et al., 2010; Maruta et al., 2017). It is also important to note that attention 
may vary over time and tracking subjects’ gaze following a continuous trajectory with 
their eyes may provide useful information about their attention over the course of the task 
(Maruta et al., 2010). Therefore, we believe that the detection of interrupted smooth 
pursuit eye movements by eye-tracking may be an appropriate assessment for other 
cognitively impairing conditions such as delirium. The assessment of how well the 
participant can stay engaged with the moving target can be further explored by examining 
the total duration of the eye’s gaze on the target. 
 Many eye-tracking studies have examined attentional deficits in conditions such 
as Alzheimer’s disease, schizophrenia, and ADHD but it is less studied in delirium. To 
address the current need to develop accurate, non-invasive tools to detect delirium in 
patients hospitalized in the ICU, the present study utilized the CAM-S assessment to 
assess patients for delirium severity in conjunction with eye-tracking. We hope to provide 
valuable information about the practicality of eye-tracking techniques to detect delirium 






 Studies have demonstrated high incidence of delirium in patients in various 
settings of the hospital. Delirium often occurs in patients staying in the ICU and many of 
these cases are left misdiagnosed or underdiagnosed due to its complexity and 
multifactorial causes. The tools available for delirium detection, such as the CAM-S test, 
require the scorer’s subjective input to assess the severity of each characteristic of the 
condition. Thus, researchers recognize the need for objective measures to accurately 
diagnose delirium to prevent negative patient outcomes such as prolonged hospital stays 
and increased cognitive impairment.  
 At this time, there are limited screening tests to assess for the condition and we 
recognize the current need for more accurate, accessible delirium assessments. This 
paper’s overall goal is to discuss the feasibility of eye-tracking as an objective method to 













Standard Protocol Approvals, Registrations, and Patient Consents 
 All study protocols were approved by the Partners Healthcare Institutional 
Review Board. Prior to beginning the study, verbal consent was acquired for all 
participants from either the participant or his or her surrogate. An information sheet with 
further details about the study was provided to the participants. 
 
Participant Selection 
Twenty-four participants were recruited from the inpatient and intensive care 
units at the Massachusetts General Hospital. The disease control group consisted of 16 
participants (age range = 22-77; mean = 56.25; SD = ±15.24; male n = 12; female n = 4; 
see Table 1) who had negative CAM-S assessments with a score range of 0-4. The 
delirium group consisted of 8 participants who had positive CAM-S assessments; four of 
these participants completed the oculomotor tasks (age range = 23-63; mean = 47.75; SD 
= ±17.61; male n = 2; female n = 2; see Table 2) and had a CAM-S score range of 4-11. 
Four participants in the delirium group with a CAM-S score range of 8-14 were unable to 
complete the oculomotor tasks due to sleepiness, confusion, and the eye-tracker’s 
inability to detect subjects’ eyes. Patients’ charts were reviewed, and their primary 
diagnosis was documented. In order for a participant to meet the inclusion criteria, they 




(EEG) recording to assess brain activity. Patients were excluded from the study if deemed 
unsuitable for participation by the research or medical care team due to medical, legal, 
social, or interpersonal issues that compromised the study or the routine care of patients.  
 
Table 1: Demographics and CAM-S Score of the Disease Control Group. The mean 
and standard deviation of age and CAM-S score were defined. 
Disease Control 
Subjects Age CAM-S score Sex 
1 68 0 Male 
2 57 1 Male 
3 73 1 Male 
4 22 0 Female 
5 62 3 Male 
6 69 3 Male 
7 77 2 Female 
8 41 0 Male 
9 43 2 Male 
10 39 1 Female 
11 59 2 Female 
12 65 0 Male 
13 41 1 Male 
14 65 4 Male 
15 51 3 Male 
16 68 2 Male 
Mean 56.25 1.5625 
 





Table 2: Demographics and CAM-S Score of the Delirium Group. The mean and 
standard deviation of age and CAM-S score were defined. 
Delirium 
Subjects Age CAM-S score Sex 
1 57 8 Male 
2 23 10 Male 
3 48 11 Female 
4 63 4 Female 
Mean 47.75 8.25 
 




Eye movements were binocularly captured by the Tobii Pro Fusion eye-tracker 
(Tobii Pro AB, Stockholm) at a 250 Hz sampling rate and saved to the Tobii Pro Lab 
software (Tobii Pro AB, Stockholm). The eye-tracker was mounted on a 15.6-inch 
Lenovo Thinkpad P1 Gen 2 laptop (Lenovo, Sha Tin, HK) with a 1920 x 1080 pixel 
resolution display, where the visual stimuli were presented. The 15.6-inch ASCUS 
ZenScreen MB16ACE monitor was attached to the laptop for the research assistant to 
ensure that participants were engaging in the tasks asked of them. The apparatus was set 
65 centimeters in front of the participant as the participant sat comfortably in the hospital 
bed as shown in Figure 1. To ensure accurate eye gaze capture, calibration and validation 




a gray dot as it moves around the laptop screen at five different positions. In the 
coordinate system, the top left of the screen is (0, 0) and the bottom right of the screen is 
(1, 1). The dot landed on positions (0.1, 0.1), (0.5, 0.5), (0.9, 0.1), (0.1, 0.9), and (0.9,0.9) 
for the calibration procedure and landed on positions (0.3, 0.3), (0.3, 0.7), (0.7, 0.3), and 
(0.7, 0.7) for the validation procedure. The order of these positions was randomized by 
the Tobii Pro system.  
  
 
Figure 1. Experimental Apparatus. Patients were sitting comfortably on the MGH 
hospital bed and the laptop and external monitor were set 65 centimeters in front of the 




 Visual Stimuli 
 
Gap Overlap Saccade Task 
The gap overlap saccade task included both 12 gap saccade and 12 overlap 
saccade trials and these trials occurred randomly. The circular, white target subtended an 
angle of 0.7° on a black background. Each trial began with a central fixation that was 
presented for a random period between 1500 and 2000 milliseconds. In the gap saccade 
trials, the central fixation was followed by a 200-millisecond gap which consisted of a 
blank screen before onset of the eccentric target and the target remained for 1500 
milliseconds. Figure 2a demonstrates a right gap saccade trial. In the overlap saccade 
trials, the central fixation remains on the screen as the eccentric target appears and 
overlaps for 200 milliseconds before disappearing from the screen. The target remained 
for another 1500 milliseconds as demonstrated in Figure 2b. All eccentric targets were 
either 10° to the left or right and occurred at random. Participants were instructed to 
follow the dot with their eyes without moving their head.  
 
Horizontal Smooth Pursuit Task 
 The circular, white target subtended an angle of 0.7° on a black background on 
the Lenovo laptop screen. The target moved sinusoidally left and right at 0.2 Hz. 
Participants were instructed to follow the dot with their eyes without moving their head 








Figure 2. Gap and Overlap Saccade Trials. a) Gap Saccade. The central fixation appears for a random period between 1500 
and 2000 milliseconds and is followed by a blank screen for 200 milliseconds. Finally, the target appears for 1500 
milliseconds. b) Overlap Saccade. The central fixation also appears for a random period between 1500 and 2000 milliseconds 
and stays on the screen, overlapping with the target for 200 milliseconds. The target remains for an additional 1500 




Circular Smooth Pursuit Task 
 The circular, white target subtended a visual angle of 0.7° on a black background 
and moved clockwise in a circular trajectory with radius of 5° of visual angle at 0.4 Hz. 
The participants were asked to follow the dot their eyes without moving their head as the 
target moved continuously in a circular path. 
 
Procedure 
 The research assistant assessed subjects for delirium via CAM-S and assessed for 
any challenges that the subject may face during the study session and mitigated those 
challenges. The CAM-S assessment was followed by the calibration and validation 
procedure discussed earlier, then the gap overlap saccade, horizontal smooth pursuit, and 
the circular smooth pursuit task. Both the horizontal and circular smooth pursuit tasks 
lasted 30 seconds each. Prior to each task, an instruction page was presented and 
participants were instructed to follow the dot with their eyes without moving their head. 
 
Analysis 
 Data were analyzed using the MATLAB Software. The eye-tracking metrics 
obtained were calibration and validation accuracies, saccade latencies and total gaze 








Calibration and Validation  
 The average calibration accuracy for the disease control group was 0.44° with a 
standard deviation (SD) of ±0.91° and coefficient of variation (CV) of 2.05. The median 
calibration accuracy was 0.19°. The delirium patients had an average calibration accuracy 
of 0.97° (SD= ±0.65°, CV=0.67) and median calibration accuracy of 0.96°. The average 
validation accuracies for the disease control group and delirium group were 0.88° (SD= 
±0.51°, CV= 0.58) and 1.14 ° (SD= ±0.44°, CV= 0.38) respectively. The median 
validation accuracy for the disease control and delirium group were 0.68° and 1.14°. 
Table 3 reports the calibration accuracy and validation accuracy for each participant in 
the disease control group and Table 4 shows the same metrics for each participant in the 
delirium group.  
 
Saccadic Latency in Horizontal Gap Overlap Saccade 
 Figure 3 presents the mean latency for both saccade trials for the disease control 
and delirium group. The mean latency of the gap saccades was 441.28 (SD= ±308.17; 
CV= 0.70) milliseconds and the mean latency of overlap saccades was 505.57 (SD = 
±303.83; CV=0.60) milliseconds in the disease control group. The median latencies of 
the gap and overlap saccades were 336 and 443.27 milliseconds. For the delirium group, 




mean overlap saccade latency was 579.88 (SD= ±351.80, CV=0.61) milliseconds. The 
median gap and overlap saccadic latencies were 635.64 and 519.88 milliseconds for the 
delirium group. Tables 5 and 6 report the mean and median latencies of the 12 trials for 
the gap and overlap saccades, standard deviations, and coefficient of variation for all 
participants in the disease control group. The mean and median latencies of the 12 trials 
for the gap and overlap saccades, standard deviations, and coefficient of variation for all 


















Table 3. Calibration and Validation Accuracy in Degrees in Disease Control Group. 





1 0 3.85 1.25 
2 1 0.15 0.69 
3 1 0.12 0.58 
4 0 0.16 0.46 
5 3 0.19 0.45 
6 3 0.36 1.63 
7 2 0.18 0.66 
8 0 0.27 0.49 
9 2 0.16 0.47 
10 1 0.08 0.5 
11 2 0.17 0.3 
12 2 0.19 1.96 
13 0 0.21 0.96 
14 1 0.27 1.39 
15 4 0.36 0.82 
16 3 0.39 1.51 
 
Table 4. Calibration and Validation Accuracy in Degrees in Delirium Group. 





17 8 1.63 0.71 
18 10 0.33 1.58 
19 11 0.96 1.14 








Figure 3. Mean Latency for Gap Overlap Saccade Task. The error bars represent the standard deviation for each type of 









Table 5. Mean and Median Latencies for Gap Saccade and Their Standard Deviations and Coefficient of Variation for 
the Disease Control Group.  *– indicates no data. 
Subject CAM-S score Gap mean  Gap median Gap STD Gap CV 
1 0 589.0016 588.559 70.71837774 0.120064831 
2 1 586.0462857 458.978 426.512809 0.727780074 
3 1 356.768 294.789 163.9091694 0.45942789 
4 0 287.677 262.555 128.5878436 0.446986876 
5 3 797.6069 671.6315 290.798508 0.364588757 
6 3 591.029 426.275 374.7111768 0.633997954 
7 2 -* -* -* -* 
8 0 296.148 255.7985 130.8239387 0.44175189 
9 2 321.5925 276.7745 259.9002042 0.808166248 
10 1 451.3107273 480.368 129.5891419 0.287139512 
11 2 509.3189091 315.744 419.1861219 0.82303271 
12 2 591.1728 525.279 292.1322634 0.494157146 
13 0 286.5834167 309.8405 86.30443203 0.301149428 
14 1 395.16 299.6885 320.1293292 0.810125846 
15 4 496.4431667 270.846 502.3813065 1.011961369 








Table 6. Mean and Median Latencies for Overlap Saccade and Their Standard Deviations and Coefficient of Variation 
for the Disease Control Group. 
.Subject CAM-S score Overlap mean Overlap STD Overlap CV 
1 0 863.381 544.9975949 0.631236493 
2 1 529.659875 157.2586585 0.296904987 
3 1 536.0438182 101.3201433 0.189014666 
4 0 786.12725 621.9065091 0.791101579 
5 3 745.6058 158.3907866 0.212432342 
6 3 268.20325 182.4405313 0.680232366 
7 2 386.644 0 0 
8 0 281.9016 168.9553235 0.599341485 
9 2 360.2563333 231.992657 0.64396552 
10 1 469.1973636 140.7901601 0.300065966 
11 2 502.2746 180.1199733 0.358608564 
12 2 503.8232 251.7349419 0.499649365 
13 0 379.9121667 114.8811619 0.302388741 
14 1 652.6390909 454.729502 0.696754927 
15 4 349.58 198.5845189 0.568066019 







Table 7. Mean and Median Latencies for Gap Saccade and Their Standard Deviations and Coefficient of Variation for 
the Delirium Group. *– indicates no data. 
Subject CAM-S score Gap mean  Gap median Gap STD Gap CV 
17 8 670.9427778 687.469 292.3110662 0.435672126 
18 10 636.9415 636.9415 339.4628738 0.532957695 
19 11 624.2284286 533.784 306.6594863 0.491261648 
20 4 -* -* -* -* 
 
 
Table 8. Mean and Median Latencies for Overlap Saccade and Their Standard Deviations and Coefficient of Variation 
for the Delirium Group.  *– indicates no data. 
Subject CAM-S score Overlap mean Overlap median Overlap STD Overlap CV 
17 8 704.0198333 519.7465 423.264358 0.601210844 
18 10 552.872 552.872 0 0 
19 11 500.1156667 477.824 318.2474986 0.636347789 






Figure 4. Gap Overlap Saccade X-Coordinate Position of Gaze Over Time. a) The x-
coordinate position over time of Subject 13 in the disease control group with a CAM-S 
score of 0. b) The x-coordinate position over time of Subject 19 in the delirium group 




Total Target Gaze Duration in Smooth Pursuit 
Tables 9 and 10 report the total duration of gaze on the horizontal and circular 
smooth pursuit target in the disease control and delirium patients. The average gaze 
duration for the horizontal smooth pursuit target in the disease control and delirium 
groups were  8.09 (SD= ±6.34, CV= 0.78) and 4.11 seconds(SD= ±5.83, CV= 1.42). The 
median gaze duration for the horizontal smooth pursuit target for the disease control and 
delirium groups were 9.43 and 1.91 seconds respectively. The average gaze duration for 
the circular smooth pursuit target in the disease control and delirium groups were 6.67 
(SD= ±4.78, CV= 0.72) and 4.05 seconds (SD= ±3.27, CV=0.81).  The median gaze 
duration for the circular smooth pursuit target for the disease control and delirium groups 
were 7.75 and 4.51 seconds. Figure 6 shows the x-position of the gaze over time of one 
subject from each group for the horizontal smooth pursuit task. Figure 7 demonstrates the 
x-position of the gaze over time and X, Y- coordinates of one subject from each group for 

















Pursuit Duration (ms) 
Circular Smooth Pursuit 
Duration (ms) 
1 0 0 0 
2 1 11372 7485 
3 1 17040 16268 
4 0 504 3335 
5 3 11743 8008 
6 3 7154 607 
7 2 185 5603 
8 0 12754 9557 
9 2 8945 11403 
10 1 12791 11562 
11 2 11466 8074 
12 2 1877 1188 
13 0 19852 9663 
14 1 9905 2965 
15 4 1654 845 
16 3 2244 10131 
 
 






Pursuit Duration (ms) 
Circular Smooth Pursuit 
Duration (ms) 
17 8 578 7189 
18 10 3233 2871 
19 11 12605 6156 






Figure 5. Horizontal Smooth Pursuit X-Coordinate Gaze Position Over Time. a) The 
x-coordinate position over time of Subject 13 in the disease control group with a CAM-S 
score of 0. b) The x-coordinate position over time of Subject 19 in the delirium group with 





Figure 6. Circular Smooth Pursuit X-Coordinate Gaze Position Over Time and X, Y-
Coordinates. a) The x-coordinate position over time and X, Y-coordinates of Subject 13 
in the disease control group with a CAM-S score of 0. b) The x-coordinate position over 







 The study of eye movements in delirious patients is poorly understood in the 
research community, therefore, the present study seeks to assess the feasibility in utilizing 
eye-tracking methods to detect delirium. We have used gap and overlap saccade and 
smooth pursuit paradigms in our experimental procedure and examined the calibration 
and validation data, saccadic latencies, and total gaze duration on the smooth pursuit 
target in the eye gaze data. 
 
Horizontal Gap Overlap Saccades 
 Figure 4 shows Subject 13 and 19’s x- position in gaze over time for the 
horizontal gap overlap saccade task. Here, we see some differences in gaze between 
Subject 13 in the disease control group with a CAM-S score of 0 and Subject 19 in the 
delirium group with a CAM-S score of 11. Subject 19 has more missing data points on 
the plot and may suggest inattentiveness or poor tracking. It also appears that Subject 19 
is making multiple short saccades along the way to the target saccade destination. These 
multiple short saccades suggest dysmetria, or the impaired performance in accurate 
movements (Manto, 2009). More specifically, this is an example of hypometria where the 
subject demonstrated undershoot in reaching the target saccade, resulting in short 




Previous studies have demonstrated that reduced brain volume in the cerebellum, 
thalamus, and frontal lobes are associated with visual attention impairment in delirious 
patients who were discharged from the ICU (Gunther, et al, 2012). Cavallari et al. (2016) 
found patients with abnormalities of the corpus callosum, thalamus,and cerebellum to 
have increased incidence and severity of delirium. This study also found that 
abnormalities of the cerebellum was most significantly associated with postsurgical 
delirium. According to Schmahmann (2004), the universal cerebellar impairment is 
dysmetria which includes dysmetria in eye movements. This type of dysmetria is 
referring to the inability to control eye movements, thus resulting in inaccurate saccades. 
The cerebellum plays a vital role in managing the accuracy of saccades and does so by 
providing the drive towards the target, tracking the target, and ending the saccade by 
eliminating the drive (Leigh and Zee, 2006; Quaia, Lefèvre, & Optican, 1999). In 
addition, lesions on the cerebellum may result in permanent damage towards the 
maintenance of saccades (Optican & Robinson, 1980). These lesions would not abolish 
an individual’s oculomotor function, but would rather slow it down and making them 
more variable and imprecise (Robinson & Fuchs, 2001). Therefore, possible cerebellar 
damage in our subjects with delirium may explain the catchup saccades to compensate 
for the undershoot.  
  




 Our calculated means and medians for the gap and overlap saccadic latency for 
the delirium group appear to be longer than that of the disease control group. This is 
consistent with previous studies that have demonstrated longer latencies in the disease 
group (Crawford, et al., 2013; Yang, Wang, Su, Xiao, & Kapoula, 2013). However, based 
on the standard deviation error bars in Figure 3, there is some overlap in saccadic 




Similar to Figure 4, we notice some differences in gaze between Subject 13 and 
19 in Figure 5, which shows the x-coordinate position over time for the horizontal 
smooth pursuit task. We notice that Subject 13’s gaze appears more continuous and 
smooth than that of Subject 19’s. From Figure 5b, we see that Subject 19 seems to follow 
the path of the horizontal smooth pursuit but her gaze appears more jagged than that of 
Subject 13’s.  In the circular smooth pursuit task, we notice some differences in eye 
movements between Subjects 13 and 19 as well (Figure 6). Similar to the horizontal 
smooth pursuit data, Subject 19’s the circular smooth pursuit gaze data suggest more 
irregular movements than Subject 13’s, who’s gaze appears more smooth and continuous. 
In Figure 6b, right plot shows Subject 19’s gaze in X,Y coordinates and we notice more 
data points located further out of the circular trajectory than that of Subject 13’s. As 




oculomotor function, resulting in the variable and imprecise eye movements we are 
witnessing in  Subject 19’s eye gaze for the horizontal and circular smooth pursuit tasks.  
 
Total Gaze Duration on Target 
The mean and median total gaze duration on the horizontal and circular smooth 
pursuit targets in the disease control gorup are longer than that in the delirium group. We 
captured the duration our patients maintained their gaze on the target; longer gaze 
duration on the target suggests longer sustained attention.  These metric results are 
consistent with our belief that the disease control subjects would have longer sustained 
attention or longer gaze duration throughout the smooth pursuit tasks. However, like the 
saccadic latencies, there is some overlap in the gaze duration between the two groups that 
may also be attributable to poor calibration and validation.   
 
Calibration and Validation Accuracy 
 In addition to the cerebellar damage that may have occurred in some of our 
patients, the calibration and validation may have contributed to the highly variable eye 
gaze data. According to Tables 3 and 4, the calibration and validation accuracies for 
Subject 13 are 0.21° and 0.96° and for Subject 19 are 0.96° and 1.14° respectively, 
indicating that Subject 19 has poorer calibration and validation. The calibration and 
validation accuracy values suggest how far away the eye gaze is from the real visual 




high variation in the calibration accuracy in disease control patients with a CV of 2.05 
and the delirium group’s calibration accuracy had a coefficient of variation of 0.67. This 
may be due to the highly variable conditions that the patients are being treated for at 
MGH. According to Tobii Pro (n.d.), factors that can result in problematic eye-tracking 
include glasses with more than one power, eye surgery, and other ocular abnormalities. 
Some of our patient participants have ocular conditions and had ocular surgery in the 
past, which greatly affects eye tracking. These conditions and surgeries include cataract 
surgery, strabismus surgery, and occlusion in the eye, leading to partial blindness. Eye-
trackers work by calculating a vector formed by the angle between the cornea and pupil 
reflection and ultimately using this vector to calculate the gaze direction (Tobii Pro, n.d.). 
The cataract and strabismus surgeries our participants had may leave scar tissue on the 
cornea which affects the eye-tracker’s ability to capture the corneal reflection, resulting 
in poor calibration.  
 
Limitations 
 Recruitment of patients from the inpatient units and ICU is challenging for the 
patients who are receiving intensive level of care. Throughout the course of treatment, 
hospitalized patients may often feel exhausted, sleep-deprived and confused due to the 
treatments they receive and disruptions from loud medical equipment and hospital staff. 
These factors along with the recruitment restraints due to the COVID-19 pandemic 




limitation is the setting of study sessions. The study sessions took place in hospital rooms 
in the ICU or inpatient unit at MGH and there were distractions coming from the 
hallways, medical equipment, and patients in the adjacent bed. These noises may have 
some part in distracting our subjects, affecting their ability to fully attend to the 
oculomotor tasks asked of them. 
 
Implications for Future Research 
  In this study, we closely examined calibration and validation data, saccade 
latencies, and total gaze duration on the smooth pursuit target in disease control and 
delirious participants. Additional research is needed to further assess the feasibility of 
using eye-tracking to capture delirium features. One of the biggest challenges our study 
faced was recruitment in the inpatient setting where patients are often tired and unwell, 
which affected patient’s ability and motivation to complete the tasks to the absolute best 
of their abilities. In addition, our participants were diagnosed with a variety of medical 
conditions that may affect their ability to complete the oculomotor tasks or affect the eye-
tracker’s ability to calibrate. In a future study, scientists may replicate this experimental 
design and recruit for healthy controls with no pre-existing conditions that may impact 
their cognitive or oculomotor functioning instead of disease controls. Through this 
method, scientists may find more accurate eye-tracking calibration and validation data. 
Despite having positive CAM-S assessments, four of the eight participants in the delirium 




tasks. On the other hand, the four participants with a higher degree of severity in delirium 
(CAM-S score range of 8-14) were unable to follow the visual stimuli. This information 
may be helpful for researchers who are interested in replicating this experimental design 
in patients with milder delirium who are more likely to understand that task instructions 
and complete the oculomotor battery. Researchers may also investigate the correlation 
between the eye-tracking metrics and CAM-S scores. This would provide useful 
information about the level of severity of delirium features captured by eye-tracking. 
 The present study recruited participants from MGH with a wide variety of 
diagnoses and conditions. Many of our participants presented to the hospital for 
headaches, seizures, and altered mental status and were admitted for further evaluation 
via EEG recordings. With delirium being multifactorial and complex, accurate 
assessment of the condition is challenging. Previous studies have shown that eye-tracking 
has been an effective assessment for attention and have demonstrated great promise as an 
assessment for diseases such as Alzheimer’s disease (Crawford, et al., 2013; Peltsch, 
Hemraj, Garcia, & Munoz, 2014; Yang, Wang, Su, Xiao, & Kapoula, 2013). Due to 
concerns about the quality of eye-tracking calibration, we believe the eye-tracking 
metrics data may have some degree of inaccuracy. Nevertheless, we were able to capture 
and visualize the path of our subjects’ eye movements as they followed the visual stimuli. 
Through these visualizations, we observed some differences in gaze between Subject 13 




provide valuable information for the future research that will ultimately develop tools to 
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